drugset / Trial / NCT05539521
Efficacy and Safety of Remimazolam Besylate Versus Propofol for Sedation in Critically Ill Patients With Deep Sedation
Phase 2
Unknown
60 enrolled
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of remimazolam besylate compared to propofol for sedation in critically ill patients with deep sedation.
Timeline
- Start
- 2022-09-05
- Primary completion
- 2023-02
- Completion
- 2023-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Propofol | Small molecule | 3 mg/kg | — |
| Subject | Remimazolam | Small molecule | 0.3 mg/kg | — |
Indications
No indication recorded.